Medtronic PLC (MDT)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$99.87

Buy

$100.30

arrow-up$0.12 (+0.12%)

Prices updated at 13 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Geoffrey S. Martha

CEO

Mr. Geoffrey S. Martha

Most recent earnings

30 Apr 2025

Fiscal year end

30 Apr 2025

Employees

95,000

Head office

Parkmore Business Park West

Galway

Ireland

1

+353 14381700

investor.relations@medtronic.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. William R. Jellison Independent Director	-
Mr. John P. Groetelaars Independent Director	-
Mr. Skip Harry Kiil Executive Vice President and President, Cardiovascular Portfolio	-
Ms. Que Thanh Dallara Chief Executive Officer, New Diabetes	-
Mr. Michael Carter Senior Vice President and President, Cranial and spinal-Technologies business	-
Dr. Joon Lee Independent Director	-
Mr. Craig Arnold Lead Independent Director	0.24m
Mr. Kendall J. Powell Independent Director	0.18m
Ms. Lidia L. Fonseca Independent Director	0.18m
Mr. Randall J. Hogan, III Independent Director	0.21m
Mr. Ivan K. Fong Executive Vice President, General Counsel and Corporate Secretary	-
Mr. Scott C. Donnelly Independent Director	0.19m
Mr. Kevin E. Lofton Independent Director	0.20m
Mr. Brett A. Wall Executive Vice President and President, Neuroscience Portfolio	0.77m
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board	1.35m
Dr. Elizabeth G. Nabel, M.D. Independent Director	0.20m
Mr. Gregory P. Lewis Independent Director	0.20m
Mr. Michael Marinaro Executive Vice President and President, Medical Surgical Portfolio and Americas	-
Mr. Matthew R. Walter Senior Vice President and Chief Human Resources Officer	-
Mr. Thierry Pieton Chief Financial Officer and Executive Vice President	0.88m
Ms. Denise L. Blomquist Vice President, Global Controller and Chief Accounting Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	126,909,406
BlackRock Inc	119,568,806
JPMorgan Chase & Co	104,391,528
State Street Corp	60,460,537
Vanguard Investments Australia Ltd	41,025,480

Director dealings

Date chevron-l-regular chevron-r-regular	Action
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
10 Dec 2024	-
06 Dec 2024	-
06 Dec 2024	-
20 Aug 2024	-
15 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-
02 Aug 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.